Composition
- Active substance
- gusperimus trihydrochloride
- International name (INN)
- gusperimus
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Spanidin
- Active substance
- gusperimus trihydrochloride
- Therapeutic area
- Wegener Granulomatosis
- Marketing authorisation holder
- Euro Nippon Kayaku GmbH
- Status
- Application withdrawn
- EMA product number
- EMEA/H/C/000809
EMA designations
- Orphan medicine
- Yes
- Conditional approval
- No
- Biosimilar
- No
- Generic
- No
- Accelerated assessment
- No
- Additional monitoring
- No
- Patient safety information
- No